This site is intended for healthcare professionals only

Coronavirus: £20 million invested into COVID-19 research

Written by: | Published:

Six projects will be funded by the investment Six projects will be funded by the investment

Trials for a new coronavirus vaccine are among six projects to receive a share of a £20 million investment from the Government, the Department of Health and Social Care has announced.

Six coronavirus research projects will be the first to benefit from a share of £20 million in government investment. Two government-backed projects will receive new funding, enabling pre-clinical and clinical vaccine trials, as well as supporting researchers to develop manufacturing processes to produce a vaccine at a million-dose scale.

‘In the midst of a global health emergency the UK is using all its extensive research expertise to quickly develop new vaccines to target this international threat,’ said Health Secretary Matt Hancock.

‘This investment will speed up globally-recognised vaccine development capabilities and help us find a new defence against this disease.’

Alongside the clinical trials, other projects include repurposing existing therapies. Patients being treated by the NHS for coronavirus are taking part in a new clinical trial to test existing therapies developed for other conditions such as HIV. These therapies might help improve patients’ recovery

Additionally researchers are developing antibodies that target coronavirus. Researchers are aiming to develop a new coronavirus therapy by developing antibodies that target the disease – doing so will help treat a range of coronavirus infections and help people’s immune systems recognise the disease and destroy it.

‘The world faces an unprecedented challenge in our efforts to tackle the spread of COVID-19 and it is vital we harness our research capabilities to the fullest extent to limit the outbreak and protect life,’ said Chief Medical Officer Professor Chris Whitty.

‘Alongside the world-leading research overseen by the NIHR, these new 6 projects will allow us to boost our existing knowledge and test new and innovative ways to understand and treat the disease.’

What do you think? Leave a comment below or tweet your views to @IndyNurseMag

This material is protected by MA Healthcare Ltd copyright.
See Terms and Conditions.

Comments

Name
 
Email
 
Comments
 

Please view our Terms and Conditions before leaving a comment.

Change the CAPTCHA codeSpeak the CAPTCHA code
 

Most read articles from Practice Nursing Journal

Practice Nursing Journal latest issue and most read articles.

Click here to read a selection of free to access articles from Practice Nursing Journal

Newsletter

Sign up to the newsletter

About

Independent Nurse is the professional resource for primary care and community nurses, providing clinical articles for practice nurses and prescribers.

Newsletter

Subscribe to our newsletter and stay up to date with the latest nursing news.

Stay Connected

Stay social with Independent Nurse by following us on Twitter, liking us on Facebook or connecting on LinkedIn.

Archive

Need access to some of our older articles? You can view our archive, or alternatively contact us.

Contact Us

MA Healthcare Ltd.
St Jude's Church, Dulwich Road
London, SE24 0PB

Tel: +44 (0)20 7738 5454
Registered in England and Wales No. 01878373

Meet the team

Authors

Find out how to contribute to Independent Nurse here.